Livanova Plc (LIVN)

May 13, 2025

LIVN Stock Rating Reiterated at 'Buy' by Needham Analyst | LIVN - GuruFocus

May 13, 2025

May 13, 2025

LivaNova PLC (NASDAQ:LIVN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 13, 2025

How to Take Advantage of moves in (LIVN) - news.stocktradersdaily.com

May 13, 2025

May 12, 2025

LivaNova PLC: Strong Growth Amidst Challenges in Earnings Call - TipRanks

May 12, 2025

May 12, 2025

Electroceuticals Market Top PlayersMedtronic Plc (Ireland), - openPR.com

May 12, 2025

May 09, 2025

Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com

May 09, 2025

May 09, 2025

New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator - Sleep Review

May 09, 2025

May 08, 2025

Jefferies lifts Livanova stock price target to $79 from $74 - Investing.com Australia

May 08, 2025

May 08, 2025

LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus

May 08, 2025

May 08, 2025

LivaNova Q1 2025 revenue increases 7.4% to USD 316.9M - Medical Buyer

May 08, 2025

May 08, 2025

Barclays Adjusts LivaNova (LIVN) Price Target Amid Strong Performance | LIVN Stock News - GuruFocus

May 08, 2025

May 08, 2025

LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo Finance

May 08, 2025

May 08, 2025

LivaNova PLC Reports Strong Q1 2025 Results - TipRanks

May 08, 2025

May 07, 2025

Jefferies lifts Livanova stock price target to $79 from $74 By Investing.com - Investing.com South Africa

May 07, 2025

May 07, 2025

LivaNova: Q1 Earnings Snapshot - MySA

May 07, 2025

May 07, 2025

LivaNova PLC earnings beat by $0.12, revenue topped estimates - Investing.com Nigeria

May 07, 2025

May 07, 2025

LivaNova PLC SEC 10-Q Report - TradingView

May 07, 2025

May 07, 2025

Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance

May 07, 2025

May 07, 2025

LivaNova Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025

May 07, 2025

Will LivaNova's Growth And Innovation Drive Sustained Gains In 2025? - Nasdaq

May 07, 2025

May 07, 2025

LivaNova submits nerve stim for sleep apnea to FDA, raises 2025 guidance - MassDevice

May 07, 2025

May 07, 2025

LivaNova Q1 Adjusted Earnings, Net Revenue Rise; 2025 Outlook Revised - marketscreener.com

May 07, 2025

May 07, 2025

LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 07, 2025

May 07, 2025

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance

May 07, 2025

May 07, 2025

LIVN Surpasses Q1 Revenue Expectations with Robust Growth | LIVN Stock News - GuruFocus

May 07, 2025

May 07, 2025

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - BioSpace

May 07, 2025

May 07, 2025

LivaNova PLC Q1 2025 Earnings: Revenue Hits $316.9M, Adjusted EPS Soars to $0.88, Both Surpass Estimates - GuruFocus

May 07, 2025

May 07, 2025

LIVN Reports Promising 12-Month Results from OSPREY Sleep Apnea Trial | LIVN Stock News - GuruFocus

May 07, 2025

May 07, 2025

LivaNova plc (LIVN) Tops Q1 EPS by 12c ; Offers Guidance - StreetInsider

May 07, 2025

May 07, 2025

Earnings Flash (LIVN) LIVANOVA PLC Reports Q1 Revenue $316.9M, vs. FactSet Est of $302.4M - marketscreener.com

May 07, 2025

May 07, 2025

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy | LIVN Stock News - GuruFocus

May 07, 2025

May 07, 2025

LivaNova Announces 12-Month Data From Osprey Clinical Study For Moderate To Severe Obstructive Sleep Apnea, Demonstrating Strong Response And Durability Of Therapy - marketscreener.com

May 07, 2025

May 07, 2025

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy - Business Wire

May 07, 2025

May 06, 2025

Should Weakness in LivaNova PLC's (NASDAQ:LIVN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

May 06, 2025

May 02, 2025

How the (LIVN) price action is used to our Advantage - news.stocktradersdaily.com

May 02, 2025

Apr 28, 2025

Medical Implants Market Projected To Witness Substantial - openPR.com

Apr 28, 2025

Apr 25, 2025

Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? - Insider Monkey

Apr 25, 2025

Apr 24, 2025

Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com

Apr 24, 2025

Apr 16, 2025

Mizuho Adjusts Price Target for LivaNova (LIVN) Ahead of Q1 Prev - GuruFocus

Apr 16, 2025

Apr 15, 2025

What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing? - Yahoo Finance

Apr 15, 2025

Apr 14, 2025

LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires - Insider Monkey

Apr 14, 2025

Apr 14, 2025

Cardiovascular Devices Market Demand, Growth and Future Scope - openPR.com

Apr 14, 2025

Apr 11, 2025

Vagus Nerve Stimulators Market Deep Research Report with - openPR.com

Apr 11, 2025

Apr 11, 2025

With LivaNova PLC (NASDAQ:LIVN) It Looks Like You'll Get What You Pay For - simplywall.st

Apr 11, 2025

Apr 11, 2025

Aortic Stenosis Market to Witness Massive Growth by 2032 | - openPR.com

Apr 11, 2025

Apr 10, 2025

10 Best UK Stocks to Buy According to Billionaires - Insider Monkey

Apr 10, 2025